Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE48.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots36.0000/ 2
- Ask / Lots51.0000/ 1
- Open / Previous Close0.0000 / 48.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 11082 | 49.945 |
| 09:38 ET | 200 | 49.64 |
| 09:39 ET | 300 | 49.4486 |
| 09:41 ET | 200 | 49.69 |
| 09:43 ET | 5109 | 50.09 |
| 09:45 ET | 1812 | 50 |
| 09:48 ET | 425 | 49.98 |
| 09:50 ET | 5000 | 49.9 |
| 09:52 ET | 2400 | 49.92 |
| 09:54 ET | 2372 | 50.01 |
| 09:56 ET | 600 | 49.925 |
| 09:57 ET | 2711 | 50.06 |
| 09:59 ET | 13027 | 50.17 |
| 10:01 ET | 8152 | 49.95 |
| 10:03 ET | 200 | 50 |
| 10:06 ET | 100 | 49.9925 |
| 10:08 ET | 500 | 49.95 |
| 10:10 ET | 1563 | 49.61 |
| 10:14 ET | 1926 | 49.545 |
| 10:15 ET | 400 | 49.465 |
| 10:17 ET | 100 | 49.495 |
| 10:19 ET | 400 | 49.35 |
| 10:21 ET | 300 | 49.18 |
| 10:26 ET | 100 | 49.15 |
| 10:30 ET | 1464 | 48.85 |
| 10:32 ET | 1750 | 48.875 |
| 10:33 ET | 2740 | 48.875 |
| 10:35 ET | 29933 | 48.595 |
| 10:37 ET | 7822 | 48.495 |
| 10:39 ET | 5588 | 48.845 |
| 10:42 ET | 3474 | 48.8 |
| 10:44 ET | 2530 | 48.43 |
| 10:48 ET | 250 | 48.53 |
| 10:50 ET | 100 | 48.65 |
| 10:51 ET | 252 | 48.72 |
| 10:53 ET | 1943 | 48.32 |
| 10:55 ET | 500 | 48.23 |
| 10:57 ET | 1708 | 48.445 |
| 11:00 ET | 2306 | 48.19 |
| 11:02 ET | 9699 | 48.13 |
| 11:04 ET | 4594 | 47.99 |
| 11:06 ET | 1447 | 48.0771 |
| 11:08 ET | 2020 | 48.085 |
| 11:09 ET | 200 | 48.045 |
| 11:11 ET | 3282 | 47.99 |
| 11:13 ET | 2450 | 48.21 |
| 11:15 ET | 1645 | 48.115 |
| 11:18 ET | 4305 | 48.13 |
| 11:20 ET | 1643 | 48.18 |
| 11:22 ET | 1120 | 48.58 |
| 11:24 ET | 200 | 48.62 |
| 11:26 ET | 908 | 48.9 |
| 11:29 ET | 2766 | 48.92 |
| 11:33 ET | 500 | 48.94 |
| 11:36 ET | 1779 | 48.5825 |
| 11:38 ET | 100 | 48.485 |
| 11:40 ET | 400 | 48.5 |
| 11:42 ET | 8774 | 48.705 |
| 11:44 ET | 3624 | 48.795 |
| 11:45 ET | 100 | 48.785 |
| 11:47 ET | 2036 | 48.725 |
| 11:49 ET | 800 | 48.78 |
| 11:51 ET | 200 | 48.63 |
| 11:54 ET | 100 | 48.59 |
| 11:56 ET | 200 | 48.62 |
| 11:58 ET | 947 | 48.72 |
| 12:00 ET | 200 | 48.69 |
| 12:02 ET | 755 | 48.605 |
| 12:03 ET | 700 | 48.47 |
| 12:05 ET | 747 | 48.355 |
| 12:07 ET | 611 | 48.28 |
| 12:09 ET | 511 | 48.43 |
| 12:12 ET | 200 | 48.46 |
| 12:14 ET | 100 | 48.44 |
| 12:18 ET | 810 | 48.53 |
| 12:20 ET | 2270 | 48.33 |
| 12:21 ET | 100 | 48.29 |
| 12:23 ET | 500 | 48.315 |
| 12:25 ET | 300 | 48.22 |
| 12:27 ET | 1288 | 48.08 |
| 12:30 ET | 268 | 48.07 |
| 12:32 ET | 1100 | 48.17 |
| 12:34 ET | 100 | 48.18 |
| 12:38 ET | 600 | 48.2799 |
| 12:39 ET | 200 | 48.215 |
| 12:41 ET | 100 | 48.25 |
| 12:43 ET | 400 | 48.28 |
| 12:45 ET | 646 | 48.18 |
| 12:50 ET | 800 | 48.28 |
| 12:52 ET | 229 | 48.26 |
| 12:54 ET | 600 | 48.32 |
| 12:57 ET | 100 | 48.33 |
| 12:59 ET | 1480 | 48.31 |
| 01:03 ET | 900 | 48.39 |
| 01:06 ET | 1123 | 48.49 |
| 01:08 ET | 200 | 48.54 |
| 01:10 ET | 100 | 48.52 |
| 01:12 ET | 1700 | 48.43 |
| 01:15 ET | 400 | 48.305 |
| 01:17 ET | 407 | 48.305 |
| 01:19 ET | 100 | 48.25 |
| 01:21 ET | 358 | 48.28 |
| 01:24 ET | 1000 | 48.33 |
| 01:26 ET | 543 | 48.34 |
| 01:28 ET | 400 | 48.37 |
| 01:30 ET | 900 | 48.37 |
| 01:32 ET | 100 | 48.29 |
| 01:33 ET | 100 | 48.37 |
| 01:35 ET | 152 | 48.36 |
| 01:37 ET | 300 | 48.42 |
| 01:39 ET | 1038 | 48.25 |
| 01:42 ET | 200 | 48.3649 |
| 01:44 ET | 1549 | 48.2687 |
| 01:46 ET | 1100 | 48.525 |
| 01:48 ET | 811 | 48.51 |
| 01:50 ET | 10734 | 48.44 |
| 01:51 ET | 412 | 48.47 |
| 01:53 ET | 300 | 48.49 |
| 01:55 ET | 500 | 48.455 |
| 01:57 ET | 308 | 48.455 |
| 02:00 ET | 3250 | 48.39 |
| 02:02 ET | 1500 | 48.41 |
| 02:04 ET | 7975 | 48.48 |
| 02:06 ET | 11488 | 48.67 |
| 02:08 ET | 14359 | 48.74 |
| 02:09 ET | 16125 | 48.77 |
| 02:11 ET | 3699 | 48.745 |
| 02:13 ET | 200 | 48.81 |
| 02:15 ET | 100 | 48.77 |
| 02:18 ET | 200 | 48.81 |
| 02:20 ET | 764 | 48.755 |
| 02:22 ET | 850 | 48.73 |
| 02:24 ET | 1479 | 48.665 |
| 02:26 ET | 9042 | 48.645 |
| 02:27 ET | 2569 | 48.82 |
| 02:29 ET | 300 | 48.725 |
| 02:31 ET | 1200 | 48.71 |
| 02:33 ET | 2722 | 48.68 |
| 02:36 ET | 1238 | 48.53 |
| 02:38 ET | 3309 | 48.605 |
| 02:40 ET | 700 | 48.75 |
| 02:42 ET | 2500 | 48.77 |
| 02:44 ET | 100 | 48.81 |
| 02:45 ET | 641 | 48.785 |
| 02:47 ET | 801 | 48.74 |
| 02:49 ET | 1250 | 48.76 |
| 02:51 ET | 1200 | 48.589 |
| 02:54 ET | 4062 | 48.695 |
| 02:56 ET | 200 | 48.655 |
| 02:58 ET | 1616 | 48.65 |
| 03:00 ET | 200 | 48.675 |
| 03:02 ET | 6610 | 48.99 |
| 03:03 ET | 600 | 49.08 |
| 03:05 ET | 845 | 48.92 |
| 03:07 ET | 200 | 48.93 |
| 03:12 ET | 700 | 48.9275 |
| 03:14 ET | 2168 | 49.245 |
| 03:16 ET | 2200 | 49.19 |
| 03:18 ET | 100 | 49.095 |
| 03:20 ET | 1850 | 49.045 |
| 03:21 ET | 1112 | 49.065 |
| 03:23 ET | 420 | 49.07 |
| 03:25 ET | 5230 | 48.985 |
| 03:27 ET | 1367 | 49.06 |
| 03:30 ET | 2800 | 49.03 |
| 03:32 ET | 3113 | 49.039 |
| 03:34 ET | 500 | 49.045 |
| 03:36 ET | 4131 | 48.91 |
| 03:38 ET | 1709 | 48.92 |
| 03:39 ET | 640 | 48.855 |
| 03:41 ET | 1473 | 48.78 |
| 03:43 ET | 1500 | 48.83 |
| 03:45 ET | 2757 | 48.69 |
| 03:48 ET | 1402 | 48.885 |
| 03:50 ET | 2411 | 48.69 |
| 03:52 ET | 10522 | 48.42 |
| 03:54 ET | 35393 | 48.552 |
| 03:56 ET | 23332 | 48.02 |
| 03:57 ET | 25361 | 48.17 |
| 03:59 ET | 295633 | 48 |
May 10, 2024
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:38PM ET on Friday May 10, 2024 by Dow Jones
5:38PM ET on Friday May 10, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 3:50PM ET on Friday May 10, 2024 by Dow Jones
3:50PM ET on Friday May 10, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 12:55PM ET on Friday May 10, 2024 by Dow Jones
12:55PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
*DJ Crinetics Pharmaceuticals 1Q Loss/Shr 93c >CRNX, from 4:06PM ET on Thursday May 09, 2024 by Dow Jones
4:06PM ET on Thursday May 09, 2024 by Dow JonesCrinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:06PM ET on Thursday May 09, 2024 by Dow Jones
4:06PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.8B | -12.7x | --- |
Nuvalent Inc | 4.2B | -27.2x | --- |
Immunovant Inc | 4.3B | -16.1x | --- |
Summit Therapeutics Inc | 3.3B | -3.0x | --- |
Madrigal Pharmaceuticals Inc | 4.4B | -8.9x | --- |
Biohaven Ltd | 3.1B | -6.3x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.8B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.7x |
Price/Sales (TTM) | 1,914.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
